Zobrazeno 1 - 10
of 621
pro vyhledávání: '"R B Colvin"'
Autor:
R I Kushak, D C Boyle, I A Rosales, J R Ingelfinger, G L Stahl, M Ozaki, R B Colvin, E F Grabowski
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0220483 (2019)
E. coli associated Hemolytic Uremic Syndrome (epidemic hemolytic uremic syndrome, eHUS) caused by Shiga toxin-producing bacteria is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and acute kidney injury that cause acute renal f
Externí odkaz:
https://doaj.org/article/4fc9251d1b8d455288bdaf2592e3da63
Autor:
W. Sommer, J. M. O□, K. B. Pruner, A. Bean, A. Dehnadi, I. Hanekamp, R. B. Colvin, G. Benichou, T. Kawai, J. C. Madsen
Publikováno v:
The Thoracic and Cardiovascular Surgeon.
Autor:
D. C. Brown
Publikováno v:
The Journal of Pathology. 158:360-360
Autor:
Ettenger RB; Division of Nephrology, Department of Pediatrics, UCLA Mattel Children's Hospital, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Seifert ME; Division of Pediatric Nephrology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA., Blydt-Hansen T; Multi-Organ Transplant Program, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Briscoe DM; Division of Nephrology, Department of Pediatrics Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Holman J; Transplant Genomics Inc., Framingham, Massachusetts, USA., Weng PL; Division of Nephrology, Department of Pediatrics, UCLA Mattel Children's Hospital, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Srivastava R; Division of Nephrology, Department of Pediatrics, UCLA Mattel Children's Hospital, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Fleming J; Transplant Genomics Inc., Framingham, Massachusetts, USA., Malekzadeh M; Division of Nephrology, Department of Pediatrics, UCLA Mattel Children's Hospital, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Pearl M; Division of Nephrology, Department of Pediatrics, UCLA Mattel Children's Hospital, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Publikováno v:
Pediatric transplantation [Pediatr Transplant] 2024 Sep; Vol. 28 (6), pp. e14836.
Publikováno v:
The Journal of Immunology. 155:3674-3682
An anti-CD3:anti-CD25 (CD3,25) bispecific mAb was developed with the objective of combining the advantages of the parent anti-CD3 and anti-CD25 mAbs. The in vivo effects of the CD3,25 were examined in comparison to the parent Abs. The CD3,25 was well
Publikováno v:
The Journal of Immunology. 152:5135-5141
Obstructive lesions in arterial vessels of transplanted organs constitute an important factor in the late failure of these organs, especially for the heart. The absence of obstructive lesions in syngeneic donor-recipient combinations, suggests that t
Autor:
Grimus, Sarah1,2,3, Sarangova, Victoria4, Welzel, Petra B.4, Ludwig, Barbara5,6,7,8, Seissler, Jochen9, Kemter, Elisabeth1,2,3,7, Wolf, Eckhard1,2,3,7 ewolf@genzentrum.lmu.de, Ali, Asghar1,2,3
Publikováno v:
Advanced Science. 8/21/2024, Vol. 11 Issue 31, p1-27. 27p.
Autor:
Liu, Yongfeng1,2,3 (AUTHOR), Kong, Jianping1,2 (AUTHOR), Liu, Gongyu1,2 (AUTHOR), Li, Zhaoxing1,2,4 (AUTHOR), Xiao, Yibei1,2,4 (AUTHOR) yibei.xiao@cpu.edu.cn
Publikováno v:
Advanced Science. 7/24/2024, Vol. 11 Issue 28, p1-23. 23p.
Autor:
Kokxin Fang1, Md. Nor, Norefrina Shafinaz1 efrina@ukm.edu.my
Publikováno v:
Malaysian Applied Biology. Jun2024, Vol. 53 Issue 2, p1-20. 20p.
Publikováno v:
The Journal of Immunology. 150:1619-1628
T cells are major mediators of graft rejection and many autoimmune diseases. During the Ag recognition process, T cells often become activated. We tested the hypothesis that an anti-CD3:anti-CD25 (CD3,25) bispecific mAb (BSMAB) can effectively and se